Research Article
Optimal Strategy for Colorectal Cancer Patients’ Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9
Table 2
The results of CTC, CTEC, CEA, and CA19-9 levels between CRC patients and controls.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CTC and CTEC positive: ≥1 CTC/7.5 mL, CEA positive: >10.9 ng/mL, and CA19-9: >37 U/mL. |